Image courtesy of Sergio Grinstein, University of Toronto, Ontario, Canada.

Remarkably little is known about the signalling pathways that drive phagocytosis. Once its prey is bound to the cell surface, what exactly causes a phagocyte to extend pseudopodia around its dinner and swallow it? In the Journal of Cell Biology, Roberto Botelho and colleagues describe the spatial and temporal regulation of two signals involved in phagocytosis, providing both a visual and an intellectual feast.

The authors made use of fluorescent probes that specifically recognize membrane lipids. Using a macrophage cell line, they first turned their attention to the phospholipid phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2). Transfection with a PtdIns(4,5)P2 probe (based on the plextrin homology (PH) domain of phospholipase Cδ fused to green fluorescent protein (PLCδ-PH-GFP)) allowed them to track the whereabouts of PtdIns(4,5)P2 in cells fed with antibody-coated erythrocytes. PtdIns(4,5)P2 accumulated in the phagocytic 'cups' as they extended round the erythrocytes, but then disappeared as soon as engulfment was complete and the vesicle membrane had fused. This was not due to membrane turnover because an acylated GFP that partitions into the inner leaflet of the plasma membrane neither accumulated as much in the phagocytic cup, nor disappeared as rapidly upon vesicle fusion. So can the transient appearance of PtdIns(4,5)P2 in the phagosome be accounted for by its local production and destruction? Apparently so: immunofluorescence revealed that type 1α phosphatidylinositol 4-phosphate 5-kinase, the enzyme that catalyses the synthesis of PtdIns(4,5)P2 from PtdIns(4)P, migrates to phagosomes as they form, then dissociates once phagocytosis is complete. But what accounts for the disappearence of PtdIns(4,5)P2? This is a tricky question as PtdIns(4,5)P2 can be either cleaved by PLC or phosphorylated by phosphatidylinositol-3-OH kinase ( PI(3)K), and both enzymes have been implicated in phagocytosis. The authors reasoned that PLCγ would be involved because activation of the Fc receptor, which stimulates phagocytosis, also activates PLCγ. Immunofluorescence with antibodies against PLCγ2 supported this hunch, which was then backed up using a probe for one of the products of PLC, diacylglycerol (DAG). This probe, based on the C1 domain of protein kinase Cδ (Cδ-GFP), showed that DAG is produced locally at the phagosome. Transfection of the two lipid probes together (one fused to yellow fluorescent protein (Cδ-YFP), the other fused to cyan fluorescent protein (PLCδ-PH-CFP)) allowed the two lipids to be tracked simultaneously (see picture: 1, early phagocytic cup; 2, later phagocytic cup; 3, early phagosome; 4, mature phagosome): as PLCδ-PH-CFP dissociated from the phagosome, Cδ-YFP became associated, reaching a peak during vesicle closure. DAG therefore seems to be produced from PtdIns(4,5)P2 by phospholipase C at the phagosome.

But are PtdIns(4,5)P2 and DAG needed for phagocytosis? Sequestration or removal of PtdIns(4,5)P2 reduced phagocytosis, as did treatment with PLC inhibitors. The PLC inhibitors prevented macrophages from forming proper phagocytic cups by blocking actin remodelling at sites of erythrocyte attachment.

The next course in this phagocytic feast might explain how changes in the levels of PtdIns(4,5)P2 and DAG affect cytoskeletal dynamics, to translate regulation into the mechanics of engulfment. Another important question concerns PtdIns(4,5)P2 metabolism. Is it all hydrolysed by PLC, or is some of it converted to PtdIns(3,4,5)P3? Probes for this lipid might soon provide an answer.